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The effects of the vasoconstrictor, phenylephrine, and the vasodilator, hydralazine, on blood flow 
to tumor were studied and compared to those on blood flow to normal tissues in vivo. Regional 
blood flow and cardiac output were measured with the use of radioactive microspheres in 150- to 
250 g inbred Harlan F344 rats bearing subcutaneous nodules of two types of transplantable 
carcinoma ("hard" and "soft") with microscopically different vascular patterns. Three groups of 
rats were treated with hydralazine, saline, or phenylephrine, and regional blood flow was 
determined at the time of maximum blood pressure response. Results were correlated with 
quantitative morphometric analysis of arteriolar and capillary wall thickness in tumor and normal 
tissue. Phenylephrine decreased, and hydralazine increased, normal tissue perfusion as indicated 
by cardiac output. Tumor blood flow remained low and was not significantly influenced by drug 
treatment, except for the phenylephrine effect on hard tumors. Histological study of tumor vessel 
walls revealed· an absence of smooth muscle capable of responding to the vasoactive drugs by 
constriction or dilation. Evidently, by their selective action on normal vessels, vasoactive drugs 
can change the ratio of tumor to normal tissue perfusion. In particular, the increase of normal 
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Changes in blood flow rate in and around tumor masses can significantly alter the effectiveness 
of chemotherapy, radiotherapy, and thermotherapy. The distribution of anticancer drugs to tumor 
tissue is influenced by blood flow to the tumor as compared with blood flow to other tissues (1). 
The efficacy of ionizing radiation therapy is known to be dependent on prevailing oxygen 
tension in irradiated tissues (2) and, in turn, tissue perfusion with oxygenated arterial blood. 
Destruction of cancer cells by hyperthermia is highly temperature-dependent, and since heat 
dissipation during local hyperthermia treatment depends largely on blood circulation (3), 
relatively low perfusion of tumor tissue is essential for selective heating of tumor masses. 
 
Quite possibly, vasoactive drugs, which either constrict or dilate arterioles, can be used to alter 
the distribution of blood flow between tumor and normal tissues to therapeutic advantage. In 
pharmacoangiography, vasoactive drugs have been employed to amplify the radiographic 
contrast between normal and cancerous tissues (4-8). In radiation therapy such drugs have been 
investigated in hopes of increasing the oxygen tension within tumors during treatments (9-13). In 
chemotherapy, such drugs may help by preferentially channeling cytotoxic drugs into the tumor 
tissue (13). The success of each of these applications requires that the drugs in some way exert a 
differential effect on the tumor compared to normal vasculature. 
 
The working hypothesis underlying the present research is that differential drug responses are 
possible because tumor vessels differ in structure and function from normal vessels. In particular, 
we have proposed that tumor vessels lack sufficient smooth muscle to constrict or to dilate in 
response to drugs that typically cause contraction or relaxation of normal resistance vessels (3). 
The objectives of the present study, therefore, are to investigate the effect of vasoactive drugs on 
tumor and normal blood flow rates with the use of the microsphere technique and to correlate the 




MATERIALS AND METHODS 
 
Animals.-- Male inbred Harlan F344 rats weighing from 150 to 250 g were used. All rats were 
caged individually and given standard laboratory chow and tap water ad libitum. An automatic 
12-hour light and dark cycle was maintained, and room temperature was maintained at 22°C.  
 
Tumors.-- The two types of tumors used in these studies have the same origin but differ greatly 
in their vasculatures. Their primary tissue source is not known, but they both diverged from a 
squamous cell carcinoma that appeared unexpectedly in the jaw of a rat being fed the carcinogen 
N-2-fluorenylacetamide (14). Divergence of the tumor types started after 1.5 years of transplant 
passage. To differentiate between the 2 tumors, we named them according to their gross textures: 
"hard" and "soft" tumors. When the rats reached the age of 6 weeks, we transplanted the tumors 
into their left hind limbs in the following manner: The donor rat was first killed with chloroform, 
the tumor was immediately exposed, and small non-necrotic sections were dissected from the 
edge and placed in balanced salt solution where they were minced. The recipient rat was sedated 
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with chloroform, and 4 pieces of tumor, each approximately 0.5 mm
3
, were inoculated sc into the 
left hind limb of each rat with a trocar needle. Tumors matured in 2-3 weeks and then rats were 
randomly assigned to treatment groups.  
 
Vasoactive drugs.-- Hydralazine hydrochloride (Apresoline, 20 mg/ml; Ciba-Geigy) was injected 
iv into 17 rats at a dose of 0.1 mg/l00 g body weight. This phthalazine derivative was chosen 
because it is a well-known, direct acting vasodilator (15). Phenylephrine hydrochloride 
(Neosynephrine; Winthrop), a vasoconstrictor, acts mainly on the -adrenergic receptors of 
peripheral blood vessels with little effect on the -receptors of the heart. Its predominant site of 
action is in peripheral vascular beds (15). A group of 17 rats received iv injections of 0.005 mg 
phenylephrine/l 00 g body weight. In control experiments, 0.3 ml of a 0.9% NaCI solution was 
administered to each of 11 animals.  
 
Anesthetic.-- Ketamine hydrochloride (Vetalar; ParkeDavis) was selected for anesthesia because 
of its minimal effects on the cardiovascular system (16). A dose of 40 mg/kg was injected i.m. 
into the right leg. This dose was effective for 2 hours. If needed, a supplement of 0.25 times the 
original dose was given.  
 
Catheters.-- All catheters used were made from PE 50 polyethylene tubing, except for the 
catheter placed in the left ventricle. This catheter employed a special design used by C. W. Song 
(personal communication). Two sizes of polyethylene tubing (PE 50 and PE 10) were joined 
together by nail polish. To standardize the length, which in turn governs the dead space, we 
connected a 6-cmlong PE 10 into a 5-cm-Iong PE 50 tubing. All catheters were connected to 23-
gauge needles, which in turn were connected to syringes filled with heparinized Ringer's 
solution.  
 
Animal preparation.-- Each rat was first weighed and anesthetized with ketamine. The femoral 
arteries were first exposed and cannulated. The right carotid artery was used for placement of the 
left ventricular catheter because it is closest to the straight portion of the ascending aorta. Then 
with a similar procedure the jugular vein was cannulated. So that clotting could be prevented, all 
catheters in position were flushed with heparinized Ringer's solution. The longer femoral 
catheter was connected to a motor-driven 1-ml syringe mounted on a Harvard withdrawal pump.  
 
Pressure was monitored before and after drug administration with the use of a Harvard Apparatus 
pressure transducer model 377 connected to a chart recorder. The transducer was calibrated 
intermittently throughout the study, and the open air zero point was established each time it was 
connected to a rat. Pressure changes were monitored via the femoral artery. The complete 
preparation procedure took approximately 30-45 minutes. For the elimination of time-dependent 
variations, all microsphere injections were done 1.5 hours after the anesthetic was administered.  
 
The drugs phenylephrine and hydralazine were dissolved in 0.9% NaCI solution, and the 
concentrations adjusted so that the total injected volume was approximately 0.1 ml to minimize 
the amount of fluid loading in the rat. All drugs were injected i.v. through the jugular vein and 
flushed with 0.2 ml saline. Microspheres were injected immediately after administration of 
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phenylephrine and 15 minutes after injection of hydralazine, at which times blood pressure 
changes produced by the drugs had stabilized.  
 






Sc were used. These spheres averaged 15 microns in diameter and were 
suspended in a solution of 10% dextran and 0.5% Tween 80. Their activity was 5 mCi/50 ml 
solution. Before injection the spheres were shaken mechanically for 30 minutes and then 
sonicated for 5 minutes.  
 
For the calibration of regional blood flow measurements, an arterial blood sample was collected 
in the 1ml syringe mounted on the Harvard withdrawal pump at a rate of 0.4 ml/minute. The 
pump was turned on 10 seconds before the microsphere injection and continued to run for 1 
minute. A microsphere suspension (0.3 ml) was injected over 20 seconds as a series of 0.I-ml 
pulses. This pulsed injection technique was used especially to promote mixing of the 
microspheres with blood in the left ventricle. Residual microspheres in the catheter were flushed 
into the left ventricle with 0.2 ml of Ringer's solution.  
 
Arterial blood collected in the 1-ml syringe was then transferred to a vial for counting, and any 
microspheres left inside the syringe were rinsed into another vial. The rat was killed by the 
injection of air into its jugular vein. Afterward, the animal was shaved, and tissue samples were 
taken from different sites to determine their radioactivity. These sites included the tumor, leg 
muscle under tumor, if any, skin covering tumor, abdominal muscle, stomach, brain, and both 
kidneys. Whenever possible, tissue samples greater than 1 g were extracted. The heart was 
opened to confirm proper placement of the catheter.  
 
The counting system used for this study was an NaI(T1) crystal counter connected to a 
multichannel analyzer (Canberra Industries, Meridien, Conn.). We prepared a standard for each 
isotope used by putting 0.1 ml of the well-sonicated microsphere suspension into a vial with 5 ml 
of saline. All standards were counted each time with the samples to eliminate the effect of decay. 
Samples with cpm less than 10 times background cpm were counted for 10 minutes, and those 
with cpm greater than 100,000 cpm were counted for 30 seconds. All other samples were 
counted for 1 minute. Window width was set to include approximately 95% peak area. Flow rate 
to each organ was determined from the following equation: flow rate/g tissue = (cpm/sample x 
syringe withdrawal rate)/(sample weight (g) x cpm of reference blood sample). Student's t-test 
for unpaired data was used to test the null hypothesis that blood flow in either drug treatment 
group was the same as that in the saline treated control group. The null hypothesis was rejected 
for values of P<.05.  
 
Histology. -- Slices (9 microns thick) were prepared with the use of standard histologic 
techniques. Twelve tumor-bearing rats, sedated with ketamine, provided tissue specimens for 
study. The thoracic cavity of each animal was quickly opened, and the tissues were perfused with 
10% formalin via an 18-gauge needle inserted into the left ventricle. Whole-body perfusion was 
maintained under constant pressure, and the perfusion rate was approximately 150 ml/10 
minutes, exiting from the cut right atrium. Tissues under investigation were then removed and 
soaked in formalin for a minimum of 24 hours before being dehydrated, embedded, sliced, and 
mounted. Dried slices were then stained, one set with Masson trichrome technique and another 
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with the PAS method--the former to identify connective tissues and smooth muscle and the latter 
to identify endothelial lining. Since tumor vasculature did not have much smooth muscle, the 
PAS stain was essential for differentiating a vessel from a fixation artifact.  
 
To compare quantitatively the tumor vessels to normal vessels, we constructed density plots of 
vessels. One cross sectional slide from each rat that best represented tumor and different normal 
tissues was selected for the microscopic study. Since the focus of our study was vascular smooth 
muscle, only those vessels with a wall thickness greater than 1 micron were counted. We 
determined the area studied by tracing sections onto graph paper. Vessel wall thickness was 
measured with the use of a micrometer eyepiece on a microscope (Leitz, Wetzlar, Federal 
Republic of Germany). The wall thickness of oblique cross sections of vessels was measured 
along the smallest diameter of the vessel profile. Then the number of vessels per unit area was 
determined by being counted and was plotted as a function of wall thickness to display 





Blood Flow and Vascular Resistance  
 
Intravenous infusion of hydralazine caused an overall increase in cardiac output of 30% 
compared to the output in saline-treated controls, whereas phenylephrine caused a 28% decrease. 
Similar results were obtained for the following major organs: kidney, brain, and stomach (text-
fig. 1). For the control rats given the saline injection, the average cardiac output was 34.34 
ml/minute/ 100 g body weight ± 12.52 SD. With hydralazine the average cardiac output was 
47.81 ml/minute/l00 g ± 12.11 SD, and with phenylephrine it was 26.3 ml/minute/ 100 g ± 6.48 
SD. Total peripheral vascular resistance of the animal under the influence of drug was found to 
be 2.4 mm Hg/ml/minute/100 g ± 0.23 SE. with hydralazine and 6.96 mm Hg/ml/minute/100 g ± 
0.60 SE with phenylephrine. The control rats had an average resistance of 3.71 mm 
Hg/ml/minute/l00 g ± 0.40 SE. These together with the individual organ and tumor resistance are 
shown in text-figure 2. Blood flow rates to the 2 tumor types are displayed in text-figure 3. 
Except for the effect of phenylephrine on hard tumors, there was no significant influence of these 





TEXT-FIGURE 1.-Cardiac output and regional blood flow (ml/min/100 g body wt) of 
normal tissues in rats under the influence of hydralazme (0.1 mg/100 g, i.v.), 0.9% 





TEXT-FIGURE 2.-Effects of hydralazine, saline, and phenylephrine on the peripheral 
vascular resistance on the peripheral vascular resistance and resistances of individual 







TEXT-FIGURE 3.-Tumor blood flow rate (ml/min/ I00 g body wt) under the influence 
of hydralazine (0.1 mg/100 g, i.v.), 0.9% NaCl, and phenylephrine (0.005 mg/100 g 





Histologic examination showed morphologic features characteristic of squamous cell 
carcinomas. The majority of the vessels in both tumor types were sinusoids with very thin walls. 
Normal vessels recruited by the tumors were easily seen along the periphery. However, due to 
the striking lack of smooth muscle in tumor vessels, traditional methods for classifying blood 
vessels do not apply, and most vessels could not be recognized, except under PAS stain, which 
marks the endothelial lining. Hard tumors had more vessels with measurable wall thickness than 
did soft tumors. As in kidneys and stomach, the vascular distribution for hard tumors decreased 
exponentially as a function of wall thickness, whereas the distribution for soft tumors was clearly 
abnormal with a paucity of large vessels. Compared to normal stomach and kidney, both tumor 
types have a very limited number of vessels with wall thicknesses greater than 7 microns (text 







TEXT-FIGURE 4.-Distribution of vessel wall thicknesses In stomach, kidney, hard 





Results in this study confirm previous reports describing tumor blood vessels as sinusoidal 
capillary beds that are maximally dilated during tumor growth (17-22). Instead of having a 
normal microvasculature, these tumors are nourished by a sinusoidal capillary bed connected 
both in parallel and in series with normal vessels at the periphery of the tumor. These sinusoids 
in general have very poorly developed smooth muscle walls (20), which quite logically show 
little response to vasoactive drugs like hydralazine and phenylephrme that act mainly on vascular 






TEXT-FIGURE 5.-Electrical analogue to tumor and normal tissue blood flow. Rs 
variable resistance in major arteries that later branch into the different organs and 
tumor; R1, resistance of normal organs; RT , resistance of tumor; R2 , resistance of 
tumor vessels; R', resistance of normal vessels recruited by the tumor in the periphery; 
fN, blood flow rate through normal tissues; fT blood flow rate through tumors. 
 
 
The overall effects of vasoactive drugs on the distribution of blood flow can be predicted with 
the use of an electrical analogy. In text-figure 5, the heart is represented by a current source that 
provides blood to different parts of the body, depending on the peripheral vascular resistance of 
the organ. A variable series resistor Rs represents the major arteries that later branch into 
different organs and tumor, which are connected m parallel. The normal tissues or organs, 
nourished by the healthy vessels capable of responding to vasoactive drugs, are represented by 
the variable resistor R1. Although the tumor has recruited some normal vessels, R', near its 
periphery, the majority of tumor vessels, R2, are not capable of further dilation. When 
hydralazine is infused into the circulation, it will be distributed throughout the body and it will 
dilate all muscular arterioles. As a result, resistance in these vessels will decrease, causing more 
blood to flow through them. Since the number of vessels in the tumor that can respond to 
vasodilator drugs is limited, the increase in tumor flow will be small compared to that in normal 
tissues. Furthermore, if arterial blood pressure drops as a result of drug treatment while tumor 
resistance remains constant, there will be a drop in the tumor blood flow rate. 
 
This model can be used in conjunction with the histologic observations to explain subtle 
differences in the experimental results. Recall that the amount of vascular smooth muscle seen in 
the soft tumor was essentially zero, whereas some vascular smooth muscle was seen in the hard 
tumor. In terms of the model, then, when resistance in other organs decreases after hydralazine 
treatment, more blood will be channeled away from the soft tumor than from the hard tumor, 
which has some series reactive vessels, R'. With phenylephrine treatment major blood vessels 
constrict, causing Rs to increase and decreasing the flow through R1 and RT. Comparatively, RT 
in hard tumors will increase more than that in soft tumors since R' is essentially zero in soft 
tumors. As a result, there will be a relatively larger decrease in the flow rate to the hard tumor 




This correlation of vascular structure and function is reflected in the vessel density plots (text-
fig. 4) and in the change in tumor vascular resistance (text-fig. 2). Thus it seems logical to 
assume that the differential response to drugs between tumor and normal tissues is explained by 
differences in the structure of small blood vessels.  
 
In earlier studies with catecholamines, Gullino and Grantham (10, 23) observed a decrease in 
blood flow to implanted tumors in kidneys and ovaries after i.v. administration of epinephrine. 
On the contrary, Abrams et al. (4) observed that injection of epinephrine can cause an increase in 
tumor blood flow. With the use of a similar technique, however, Rockoff et al. (8) concluded that 
response to epinephrine is highly tumor type-dependent. Our results suggest that changes in 
tumor perfusion caused by vasoactive drugs depend on the microvasculature of both the tumor 
and the surrounding normal tissues. In the studies of Gullino and Grantham (10, 23) flow was 
measured in ovaries totally replaced by tumor and not in any parallel channels of normal tissues. 
Evidently, as in our hard tumor type, there was some capacity for vasoconstriction in these 
tumors, so that when epinephrine was injected selectively into the tumor circulation, tumor flow 
decreased. Alternatively, Abrams (24) gave epinephrine systemically, so that the same 
concentration of the drug perfused both normal and tumor tissues in parallel. His observation of 
increased tumor perfusion is explainable if the vasoconstrictive response of normal vessels was 
greater than in tumor vessels and if, as would be expected after systemic epinephrine 
administration, arterial blood pressure increased.  
 
Mattsson, Lilja, and Peterson (20) used the xenon clearance method to study the influence of 
vasoactive drugs on blood flow to normal subcutaneous tissue and transplanted fibrosarcomas in 
rats. They injected 0.02-ml volumes of xenon solution containing either the vasoconstrictor 
noradrenalin or the direct-acting vasodilator papaverine. After injection of noradrenaline, 
subcutaneous tissues showed a greater absolute and relative decrease in blood flow than did 
tumor tissue. Conversely, papaverine caused no change in tumor blood flow, compared to the 
flow seen in saline treated controls, but it caused a roughly 40% increase in flow to subcutaneous 
tissue. These results are entirely consistent with those of the present study and with the 
hypothesis that tumor vessels are relatively less reactive to vasoactive drugs than are normal 
vessels in normal tissues.  
 
The relative effects of vasoactive drugs on tumor versus normal perfusion are worthy of further 
study because of several potential clinical implications. In radiotherapy, for example, 
vasoconstrictors might be used to decrease normal tissue perfusion and oxygenation relatively 
more than in tumor, in order to reduce formation of oxygen-based free radicals in the normal 
tissue and enhance therapeutic gain. Similarly, in chemotherapy, such drugs may be used to 
increase the ratio of tumor perfusion to normal tissue perfusion, especially during regional intra-
arterial chemotherapy. In hyperthermia treatment, vasodilators such as hydralazine that act 
mainly on smooth muscles can be very useful in increasing blood cooling of normal tissues, 
allowing greater overall power input and temperature rise in the tumor (25). Each of these 
applications is based on the selective structural and functional abnormalities of tumor vasculature 
in relation to the surrounding normal vasculature, which provide a potential target for more 
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